NATIONAL HEALTHCARE CORP·4

Mar 6, 4:23 PM ET

KIDD BRIAN F 4

4 · NATIONAL HEALTHCARE CORP · Filed Mar 6, 2026

Research Summary

AI-generated summary of this filing

Updated

NATIONAL HEALTHCARE (NHC) CFO Brian F. Kidd Exercises Options

What Happened
Brian F. Kidd, SVP and Chief Financial Officer of National Healthcare Corp (NHC), exercised stock options on March 4, 2026. He exercised 2,000 options at $53.94 (acquiring 2,000 shares for $107,880) and 4,000 options at $90.62 (acquiring 4,000 shares for $362,480), for a total cash exercise cost of $470,360. The company withheld 3,947 shares to satisfy the exercise price and withholding tax obligations (worth approximately $682,160). The underlying option positions (2,000 and 4,000-option grants) were converted/cancelled upon exercise.

Key Details

  • Transaction date: March 4, 2026; Form 4 filed March 6, 2026 (period covered: 2026-03-04).
  • Option exercises (code M): 2,000 shares @ $53.94 ($107,880) and 4,000 shares @ $90.62 ($362,480).
  • Tax/exercise withholding (code F): 3,947 shares withheld @ $172.83 (~$682,160) to cover exercise price and taxes.
  • The 2,000- and 4,000-share derivative disposals at $0.00 reflect the option conversion/cancellation upon exercise.
  • Footnotes: options were granted under the 2020 Omnibus Equity Incentive Plan (grants dated Mar 8, 2023 and Feb 24, 2025) and are exempt from Section 16(b) under Rule 16b-3(d). Shares were withheld to pay exercise price and tax obligations (footnotes F1–F3).
  • Shares beneficially owned after the transactions are reported on the filing (see footnote F4 on the Form 4).

Context
This was an option exercise with net/share-withheld settlement (company withheld shares to cover exercise cost and taxes), a common executive compensation action rather than an open-market buy or sell. Such exercises are typically routine and do not, by themselves, indicate a change in insider sentiment.

Insider Transaction Report

Form 4
Period: 2026-03-04
KIDD BRIAN F
SVP, CFO
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-04$53.94/sh+2,000$107,88027,224 total
  • Exercise/Conversion

    Common Stock

    [F2]
    2026-03-04$90.62/sh+4,000$362,48031,224 total
  • Tax Payment

    Common Stock

    [F3][F4]
    2026-03-04$172.83/sh3,947$682,16027,277 total
  • Exercise/Conversion

    Option to Purchase Common Stock

    [F1]
    2026-03-042,0006,000 total
    Exercise: $53.94From: 2024-03-08Exp: 2028-03-08Common Stock (8,000 underlying)
  • Exercise/Conversion

    Option to Purchase Common Stock

    [F2]
    2026-03-044,0009,500 total
    Exercise: $90.62From: 2026-02-24Exp: 2030-02-24Common Stock (13,500 underlying)
Holdings
  • Option to Purchase Common Stock

    Exercise: $94.10From: 2025-03-05Exp: 2029-03-05Common Stock (8,000 underlying)
    8,000
  • Option to Purchase Common Stock

    Exercise: $157.13From: 2027-02-23Exp: 2031-02-23Common Stock (14,000 underlying)
    14,000
Footnotes (4)
  • [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
  • [F2]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
  • [F3]Shares were withheld by the Company to pay the exercise price and withholding tax obligations.
  • [F4]Total amount of shares beneficially owned following transactions reported on this form.
Signature
/s/ Brian Kidd|2026-03-06

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4